Cholesterol-lowering drugs
Amgen and Sanofi end epic battle over Praluent and Repatha
Amgen, Sanofi and Regeneron have apparently settled their dispute over the cholesterol-lowering drugs Praluent and Repatha. As JUVE Patent learned fro
...
12 March 2026 by Mathieu Klos